{
  "fields": [
    {
      "name": "Therapeutic Area",
      "type": "text",
      "aliases": ["area", "therapy area", "disease area"]
    },
    {
      "name": "Modality",
      "type": "text",
      "aliases": ["platform", "technology", "drug type"]
    },
    {
      "name": "Phase",
      "type": "phase",
      "aliases": ["stage", "development phase", "clinical stage"]
    },
    {
      "name": "Asset Name",
      "type": "text",
      "required": true,
      "aliases": ["drug", "compound", "candidate", "program"]
    },
    {
      "name": "Description",
      "type": "text",
      "aliases": ["summary", "mechanism", "moa"]
    },
    {
      "name": "Therapeutic Target",
      "type": "text",
      "aliases": ["target", "molecular target"]
    },
    {
      "name": "Indication",
      "type": "text",
      "aliases": ["disease", "condition"]
    },
    {
      "name": "Company",
      "type": "text",
      "aliases": ["sponsor", "developer"]
    }
  ]
}
